DekaBank Deutsche Girozentrale - IOVANCE BIOTHERAPEUTICS INC ownership

IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 246 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.51 and the average weighting 0.2%.

Quarter-by-quarter ownership
DekaBank Deutsche Girozentrale ownership history of IOVANCE BIOTHERAPEUTICS INC
ValueSharesWeighting
Q2 2024$797
-42.9%
100,0000.0%0.00%
-66.7%
Q1 2024$1,396
+61.0%
100,0000.0%0.00%
+50.0%
Q4 2023$867
+91.0%
100,0000.0%0.00%
+100.0%
Q3 2023$454
-35.4%
100,0000.0%0.00%
-50.0%
Q2 2023$703
+15.2%
100,0000.0%0.00%0.0%
Q1 2023$610
-3.0%
100,0000.0%0.00%0.0%
Q4 2022$629
-99.9%
100,0000.0%0.00%
-33.3%
Q3 2022$942,000
-29.3%
100,000
-19.3%
0.00%
-25.0%
Q2 2022$1,333,000
-35.6%
123,9000.0%0.00%
-20.0%
Q1 2022$2,069,000
-4.7%
123,900
+10.0%
0.01%0.0%
Q4 2021$2,171,000
-28.9%
112,600
-11.8%
0.01%
-44.4%
Q3 2021$3,055,000
-8.6%
127,6000.0%0.01%
-10.0%
Q2 2021$3,343,000
+77.5%
127,600
+100.6%
0.01%
+66.7%
Q1 2021$1,883,000
-38.3%
63,6000.0%0.01%
-45.5%
Q4 2020$3,054,000
+241.6%
63,600
+128.8%
0.01%
+175.0%
Q3 2020$894,000
-63.7%
27,800
-74.5%
0.00%
-66.7%
Q2 2019$2,462,000
+54.9%
109,000
+21.1%
0.01%
+33.3%
Q1 2019$1,589,000
+451.7%
90,000
+176.9%
0.01%
+350.0%
Q4 2018$288,000
-81.9%
32,500
-63.9%
0.00%
-77.8%
Q3 2018$1,589,000
+32.7%
90,000
-2.6%
0.01%
+12.5%
Q2 2018$1,197,000
+71.0%
92,400
+117.9%
0.01%
+60.0%
Q1 2018$700,00042,4000.01%
Other shareholders
IOVANCE BIOTHERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
MHR Fund Management 19,997,103$90,986,81911.15%
MPM BioImpact LLC 3,287,397$14,957,6563.99%
Perceptive Advisors 11,962,938$54,431,3671.82%
CM Management, LLC 200,000$910,0000.97%
Velan Capital Investment Management LP 250,000$1,137,5000.92%
Opaleye Management Inc. 610,000$2,775,5000.90%
Boxer Capital, LLC 3,705,133$16,858,3550.90%
SECTORAL ASSET MANAGEMENT INC 985,000$4,481,7500.87%
Parametrica Management Ltd 95,400$434,0700.73%
683 Capital Management, LLC 2,050,000$9,327,5010.72%
View complete list of IOVANCE BIOTHERAPEUTICS INC shareholders